Diasorin LIAISON® VZV IgG HT - HSA Registration DE0510549
Access comprehensive regulatory information for Diasorin LIAISON® VZV IgG HT in the Singapore medical device market through Pure Global AI's free database. This CLASS C IVD medical device is registered under HSA registration number DE0510549 and owned by DiaSorin Italia S.p.A.. The device was registered on April 04, 2025.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The LIAISON® VZV IgG HT assay uses chemiluminescent immunoassay (CLIA) technology for the in vitro quantitative determination of specific IgG antibodies to varicella-zoster virus (VZV) in human serum, lithium and sodium heparin and K2-EDTA plasma. This assay is intended as an aid in the determination of immune status to VZV and as an aid in the diagnosis of infection of varicella-zoster virus in individuals including pregnant women, transplanted and immunocompromised. The test has to be performed on the LIAISON® XL and LIAISON® XS analyzers only.